Expression of fibronectin and its integrin receptor alpha 5 beta 1 in canine mammary tumours.

Abstract

Fibronectin and its integrin receptor alpha 5 beta 1 were studied by immunohistochemical methods in five normal canine mammary glands, four dysplastic glands and 18 mammary tumours. The aim of the study was to evaluate the possible changes in the alpha 5 beta 1 integrin receptor and its ligand fibronectin in relation to the metastatic capacity of canine mammary neoplasms. The immunostaining of alpha 5 beta 1 was very uniform in the hyperplastic glands but uneven in the mammary tumours. The expression of alpha 5 and beta 1 was diminished in metastatic tumours but there were some alpha 5-positive cells with pronounced features of malignancy and immaturity. Stromal fibronectin was increased in most cases and cytoplasmic staining of fibronectin was observed in epithelial and myoepithelial cells in mammary neoplasms but not in normal or dysplastic mammary tissue. There was no relationship between the content of alpha 5 beta 1 and the expression of fibronectin in canine mammary tumours.

• Authors: L Peña, A Nieto, M D Perez Alenza, A Rodriguez, M A Sanchez, M Castaño
• Journal: Research in veterinary science (Res Vet Sci) Vol. 57 Issue 3 Pg. 358-64 (Nov 1994) ISSN: 0034-5288 [Print] England
• PMID: 7871257 (Publication Type: Journal Article)

Chemical References

• Fibronectins
• Receptors, Fibronectin

Topics

• Animals
• Dog Diseases (immunology, metabolism)
• Dogs
• Fibrocystic Breast Disease (metabolism, veterinary)
• Fibronectins (analysis)
• Immunoenzyme Techniques (veterinary)
• Lung Neoplasms (secondary, veterinary)
• Mammary Neoplasms, Animal (chemistry, immunology, pathology)
• Neoplasms, Glandular and Epithelial (chemistry, immunology, secondary, veterinary)
• Receptors, Fibronectin (analysis)